Device Market

BioNationLogin

Email

Password

I've forgotten my password!
Create an account here!

Therapeutic Areas

Competencies

Services

Devices

Device

DeviceBusiness News

unilife corporation announces preliminary financial results for fourth quarter and fiscal year 2010 ... Aug 30 2010
scancell signs antibody licence agreement with cancer research technology ... Aug 10 2010
photocure establishes us subsidiary to build speciality dermatology business ... Aug 4 2010
oxygen biotherapeutics, inc. (oxbo) signs crada with u.s. navy to study treatment of decompression s ... Aug 2 2010
oxygen biotherapeutics, inc. (oxbo) files fy2010 annual report on form 10-k ... Jul 26 2010
innocoll submits spa for cogenziatm phase iii clinical trials for the adjuvant treatment of diabetic ... Jul 13 2010
oxycyte(r) pfce decreases mortality from decompression sickness in preclinical study ... Jun 30 2010

Device Jobs

Find an open position today!

Profile

Device and Drug Combination Products: a New Regulatory, Reimbursement and Marketing Challenge

More and more drug-device combination products have appeared on the market, incorporating cutting edge technologies from nanotechnology, drug-delivery and gene therapy systems. by Corinne Lebourgeois , 03/11/2008

Profile

Smart Patch Technology: Focusing On Peptide Delivery

Vyteris is redirecting its business strategy towards the advancement of peptide delivery. by Fabio Ferfoglia, PhD , 07/02/2008

IPOs on the Tel Aviv Stock Exchange

11/10/2007

DeviceHeadlines

DevicePartnerships

March 21st, 2007, Medtronic Inc announced it had entered into a development agreement with OsteoGenix Incorporated. The agreement would enable OsteoGenix to complete preclinical work on its proprietary bone anabolic agent and advance this program through clinical trials. The agreement would give Medtronic an additional source of bone growth therapies for surgeons whose patients require bone grafting options.